Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors

NCT06418789 is registered in ClinicalTrials.gov with N.N. Petrov National Medical Research Center of Oncology as lead sponsor.

NCT NCT06418789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06418789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
Lead sponsor
N.N. Petrov National Medical Research Center of Oncology
Phase
Phase 2
Overall status
Recruiting
Start date
March 1, 2024
Completion date
March 1, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

germ cell tumor